<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Nuclear Medicine and Biology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Nuclear Medicine and Biology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Nuclear+Medicine+and+Biology&t=Nuclear+Medicine+and+Biology&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 03:37:48 +0100</lastBuildDate>
        <item>
            <title>Table of Contents</title>
            <link>http://www.medworm.com/index.php?rid=5652113&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111003192%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652113</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652113</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5652097&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111003155%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652097</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652097</guid>        </item>
        <item>
            <title>Table of Contents</title>
            <link>http://www.medworm.com/index.php?rid=5563476&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111002782%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563476</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563476</guid>        </item>
        <item>
            <title>Further information on the aims and scope of nuclear medicine and biology</title>
            <link>http://www.medworm.com/index.php?rid=5563458&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111002691%2Fabstract%3Frss%3Dyes</link>
            <description>The editorial board of Nuclear Medicine and Biology would like to wish you a happy new year and thank you for your support of the journal over the past year.  Over the past 5 years, we have instituted a series of editorials that address design issues in the radiopharmaceutical sciences. If you are interested in writing an editorial, please contact the editor-in-chief. If you have comments on the editorials, please submit a letter to the editor on the automated author's system at http://www.nucmedbio.com. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563458</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563458</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5563457&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111002745%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563457</comments>
            <pubDate>Sun, 01 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563457</guid>        </item>
        <item>
            <title>Characterization of 4-[18F]-ADAM as an imaging agent for SERT in non-human primate brain using PET: a dynamic study</title>
            <link>http://www.medworm.com/index.php?rid=5652109&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001880%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: 4-[18F]-ADAM appears to be a highly selective radioligand for imaging SERT in monkey brain. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652109</comments>
            <pubDate>Fri, 02 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652109</guid>        </item>
        <item>
            <title>Nonlinear compartmental model of 18F-choline</title>
            <link>http://www.medworm.com/index.php?rid=5652107&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111002150%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The simple linear model presented is not able to properly describe the biokinetics of 18F-choline as measured in prostatic cancer patients. The introduction of nonlinear kinetics, although based on physiologically plausible assumptions, resulted in nonsignificant improvements of the model predictive power. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652107</comments>
            <pubDate>Fri, 02 Dec 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652107</guid>        </item>
        <item>
            <title>[11C]Acetate rest–stress protocol to assess myocardial perfusion and oxygen consumption reserve in a model of congestive heart failure in rats</title>
            <link>http://www.medworm.com/index.php?rid=5652110&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001909%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: We describe an [11C]acetate PET rest–stress protocol for the assessment of congestive heart failure in rats and its application to the follow-up of cardiotoxicity under doxorubicin chemotherapy. This is a rapid and reliable approach to the measurement of cardiac perfusion and oxygen consumption reserve that could be applied to the development of new strategies to reduce the cardiotoxicity of anthracycline. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652110</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652110</guid>        </item>
        <item>
            <title>Radiohalogenated 4-anilinoquinazoline-based EGFR-TK inhibitors as potential cancer imaging agents</title>
            <link>http://www.medworm.com/index.php?rid=5652106&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111002149%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Introduction: The overexpression of epidermal growth factor receptor (EGFR) in tumors underlines the recent interest in EGFR as attractive target for the development of new cancer imaging agents. EGFR-tyrosine kinase inhibitors (EGFR-TKIs) based on the anilinoquinazoline scaffold have been explored as potential probes for EGFR imaging. However, up to now, no optimal radiotracer is available. Herein, we report the synthesis and biological evaluation of three novel halogenated 6-substituted 4-anilinoquinazoline based EGFR-TKIs. Radiosynthesis (125I and 18F) of the corresponding analogues was also performed.Methods: 6a, 6b and 8 were obtained by reaction of 6-amino-4-anilinoquinazoline (5) with 3-/4-iodobenzoyl and 4-fluorobenzoyl chlorides. Inhibition of EGFR autophosphorylation an...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652106</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652106</guid>        </item>
        <item>
            <title>Studies of the myocardial uptake and excretion mechanisms of a novel 99mTc heart perfusion agent</title>
            <link>http://www.medworm.com/index.php?rid=5652102&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS096980511100196X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The heart uptake mechanism of 99mTc-TMEOP is similar to that of the other reported monocationic 99mTc cardiac agents and is associated with its accumulation in the mitochondria. Cyclosporin A studies indicate that the fast liver and kidney clearance kinetics is mediated by P-glycoprotein (Pgp), supporting the potential interest of this radiotracer for imaging Pgp function associated with multidrug-resistant tumours. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652102</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652102</guid>        </item>
        <item>
            <title>Combining dose and injection volume for good performance of a specific radiopharmaceutical for sentinel node detection</title>
            <link>http://www.medworm.com/index.php?rid=5563473&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001831%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Suitable performances could be reached by proper combinations of dose, injection volume and concentration for a specific radiotracer used in sentinel lymph node detection. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563473</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563473</guid>        </item>
        <item>
            <title>[18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice</title>
            <link>http://www.medworm.com/index.php?rid=5563464&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001521%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: FES PET imaging was able to reliably differentiate between tumors having differences in their ERα expression in vivo, in a mouse model. Quantitative data obtained by FES PET were in concordance with biodistribution studies and in vitro assays. It is concluded that FES PET imaging can likely be used to monitor subtle ER status changes during the course of hormone therapy. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563464</comments>
            <pubDate>Mon, 14 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563464</guid>        </item>
        <item>
            <title>Evaluation of copper-64-labeled somatostatin agonists and antagonist in SSTr2-transfected cell lines that are positive and negative for p53: implications for cancer therapy</title>
            <link>http://www.medworm.com/index.php?rid=5652100&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001958%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Based on these in vitro data, the agonist 64Cu-CB-TE2A-Y3-TATE demonstrates the most promise as an agent for targeted radiotherapy in p53 positive, SSTr2-positive tumors. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652100</comments>
            <pubDate>Mon, 07 Nov 2011 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652100</guid>        </item>
        <item>
            <title>Contents</title>
            <link>http://www.medworm.com/index.php?rid=5470939&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111002678%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470939</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470939</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5470922&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111002551%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470922</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470922</guid>        </item>
        <item>
            <title>Radiation dose estimates for carbon-11-labelled PET tracers</title>
            <link>http://www.medworm.com/index.php?rid=5652112&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001946%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Although differing in approach, the two most widely used regulatory frameworks (those in the USA and the EU) do not differ substantially with regard to the maximum allowable injected activity per PET study. The predictive validity of animal dosimetry models is critically discussed in relation to human dosimetry. Finally, empirical PET data are related to human dose estimates based on homogenous distribution, generic models and maximum cumulated activities. Despite the contribution of these models to general risk estimation, human dosimetry studies are recommended where continued use of a new PET tracer is foreseen. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652112</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652112</guid>        </item>
        <item>
            <title>Simplified quantification and whole-body distribution of [18F]FE-PE2I in nonhuman primates: prediction for human studies</title>
            <link>http://www.medworm.com/index.php?rid=5652111&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001934%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The results in nonhuman primates suggest that [18F]FE-PE2I is suitable for accurate and stable DAT quantification, and its radiation dose estimates would allow for a maximal administered radioactivity of 476 MBq in human subjects. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652111</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652111</guid>        </item>
        <item>
            <title>Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling: Part I: PET studies</title>
            <link>http://www.medworm.com/index.php?rid=5652104&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001922%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: [18F]LBT-999 is N-dealkylated in vivo to yield (1) a nonradioactive metabolite that crosses the BBB and has a high affinity for the DAT and (2) a [18F]fluoro-alkyl chain which is further defluorinated. The temporal changes in distribution volumes are consistent with the accumulation of a radiometabolite(s) in the brain. Therefore, the quantification of DAT density with [18F]LBT-999 is rather difficult. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652104</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652104</guid>        </item>
        <item>
            <title>Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation</title>
            <link>http://www.medworm.com/index.php?rid=5652099&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001971%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: 64Cu-ATSM accumulated in cells with overreduced states due to mitochondrial dysfunction, even under normoxia. We recently reported that 62Cu-ATSM-PET can visualize stroke-like episodes maintaining oxygen supply in MELAS patients. Taken together, our data indicate that ⁎Cu-ATSM uptake reflects overreduced intracellular states, despite oxygenic conditions; thus, ⁎Cu-ATSM would be a promising marker of intracellular overreduced states for disorders with mitochondrial dysfunction, such as MELAS, Parkinson's disease and Alzheimer's disease. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652099</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652099</guid>        </item>
        <item>
            <title>Synthesis and evaluation of [18F]exendin (9–39) as a potential biomarker to measure pancreatic β-cell mass</title>
            <link>http://www.medworm.com/index.php?rid=5652098&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001910%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: [18F]Ex(9–39) was successfully prepared and used for PET imaging for the first time to measure pancreatic BCM. The results suggest that derivatization of the Lys27 residue might reduce binding affinity, as evidenced by the absence of specific binding. Exendin analogues radiolabeled at other sites may elucidate the active site required for binding. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652098</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652098</guid>        </item>
        <item>
            <title>Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody</title>
            <link>http://www.medworm.com/index.php?rid=5563472&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS096980511100182X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The radiolabeled isatins appear to bind specifically to caspase-3 in vivo, but their sensitivity is limited. Further optimization is required for these tracers to be useful for clinical applications. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563472</comments>
            <pubDate>Fri, 28 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563472</guid>        </item>
        <item>
            <title>Contents</title>
            <link>http://www.medworm.com/index.php?rid=5307272&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111002034%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307272</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307272</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5307254&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001995%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307254</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307254</guid>        </item>
        <item>
            <title>Enhanced antiproliferative effects of combination hexokinase II shRNA and NIS gene therapy on vascular smooth muscle cells</title>
            <link>http://www.medworm.com/index.php?rid=5652108&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001855%2Fabstract%3Frss%3Dyes</link>
            <description>This study was designed to determine the antiproliferative effects of combination gene therapy using sodium iodide symporter (NIS)-based radioiodine and lentivirus-mediated short hairpin RNA (shRNA) against hexokinase II (HKII) on vascular smooth muscle cells (VSMCs).Methods: A7r5 rat VSMCs were stably transfected with a dual-expression vector of NIS and Fluc (A7r5-NL cells). Functional assessment was performed by radioiodine uptake assay, luciferase assay and confocal microscopy. After exposure to lentivirus-HKII-shRNA, the 18F-FDG uptake test and HK activity assay were performed. The effects of combination therapy with 131I and lentivirus-HKII-shRNA on VSMCs were assessed with an in vitro clonogenic assay. In vivo bioluminescence and nuclear imaging were undertaken using a xenografted mo...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652108</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652108</guid>        </item>
        <item>
            <title>Synthesis and evaluation of a C-6 alkylated pyrimidine derivative for the in vivo imaging of HSV1-TK gene expression</title>
            <link>http://www.medworm.com/index.php?rid=5652105&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001892%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The biological evaluations demonstrated the feasibility of using N-methylated C-6-substituted pyrimidine derivative N-Me-[18F]FHBT as a PET radiotracer for monitoring HSV1-TK expression in vivo. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652105</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652105</guid>        </item>
        <item>
            <title>Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma</title>
            <link>http://www.medworm.com/index.php?rid=5652103&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001867%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: MRI was superior in the detection of all organ tumors compared to microCT and PET. [18F]-DOPA had overall better sensitivity than [18F]-DA for the detection of metastases. Subcutaneous tumors were localized only with [18F]-DOPA, a finding that may reflect differences in expression of VMAT1 and VMAT2, perhaps similar to some patients with pheochromocytoma where [18F]-DOPA provides better visualization of lesions than [18F]-DA. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652103</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652103</guid>        </item>
        <item>
            <title>PET study using [11C]FTIMD with ultra-high specific activity to evaluate I2-imidazoline receptors binding in rat brains</title>
            <link>http://www.medworm.com/index.php?rid=5652101&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001879%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Quantitative PET using [11C]FTIMD with ultra-high specific activity can contribute to the detection of small changes in I2R expression in the brain. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652101</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652101</guid>        </item>
        <item>
            <title>Synthesis of [11C]interleukin 8 using a cell-free translation system and l-[11C]methionine</title>
            <link>http://www.medworm.com/index.php?rid=5563474&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001843%2Fabstract%3Frss%3Dyes</link>
            <description>This study clearly demonstrates that cell-free protein production system combined with positron emitter-labeled amino acid holds great promise as a novel approach to prepare radiolabeled proteins and peptides for PET imaging. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563474</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563474</guid>        </item>
        <item>
            <title>Radiotracer properties determined by high performance liquid chromatography: a potential tool for brain radiotracer discovery</title>
            <link>http://www.medworm.com/index.php?rid=5563471&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001600%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Log P should not be relied upon as a predictor of blood-brain barrier penetration during brain radiotracer discovery. HPLC measurements of permeability, %PPB and membrane interactions may be potentially useful in predicting in vivo performance and hence allow evaluation and ranking of compound libraries for the selection of lead radiotracer candidates at early stages of radiotracer discovery. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563471</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563471</guid>        </item>
        <item>
            <title>The influence of mass of [11C]-laniquidar and [11C]-N-desmethyl-loperamide on P-glycoprotein blockage at the blood–brain barrier</title>
            <link>http://www.medworm.com/index.php?rid=5563470&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001582%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: These results demonstrate the bivalent character of laniquidar, acting as a substrate at low doses and as a blocking agent for P-glycoprotein transport in the brain at higher doses. In comparison, no difference was observed in [11C]-dLop uptake between carrier- and no-carrier-added formulations, which confirms that desmethyl-loperamide is a substrate of P-glycoprotein at the blood–brain barrier. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563470</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563470</guid>        </item>
        <item>
            <title>Transport mechanisms of trans-1-amino-3-fluoro[1-14C]cyclobutanecarboxylic acid in prostate cancer cells</title>
            <link>http://www.medworm.com/index.php?rid=5563469&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001570%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Total uptake of anti-[14C]FACBC by PCa cells correlates with the expression level of system ASC in PCa cells. Furthermore, LAT1 is an important transport system for anti-[14C]FACBC uptake, especially in an acidic environment, such as the intra-tumoural environment. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563469</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563469</guid>        </item>
        <item>
            <title>Comparing the intracellular fate of components within a noncovalent streptavidin nanoparticle with covalent conjugation</title>
            <link>http://www.medworm.com/index.php?rid=5563468&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001557%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The weaker noncovalent biotin–streptavidin bond may be essential for adequate delivery of the radiolabeled antisense oligomer to the nucleus of tumor cells. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563468</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563468</guid>        </item>
        <item>
            <title>SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies</title>
            <link>http://www.medworm.com/index.php?rid=5563465&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001569%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: These data indicate that HS expressed in amyloid deposits has unique qualities that can be distinguished from HS in normal tissues. A scFv specific for rare hypersulfated HS was used to selectively image AA amyloid in mice with minimal retention in normal tissue. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563465</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563465</guid>        </item>
        <item>
            <title>Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model</title>
            <link>http://www.medworm.com/index.php?rid=5563462&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001594%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: The biodistribution, pharmacokinetics, dosimetry and comparative therapeutic efficacy of intravenously administrated 188Re-N,N-bis(2-mercaptoethyl)-N′,N′-diethylethylenediamine (BMEDA)-labeled pegylated liposome (188Re-liposome) and 5-FU were investigated in a CT26-luc lung-metastatic model. After intravenous administration of 188Re-liposome, tumor accumulation from the radioactivity was observed. Levels of radioactivity in tumors were maintained at steady levels (from 5.40 to 5.67 %ID/g) after 4 to 24 h. In pharmacokinetics, the AUC(0→∞), MRT(0→∞) and Cl of 188Re-liposome in blood via intravenous route were 998 h %ID/ml, 28.7 h and 0.1 ml/h, respectively. The total excreted fractions of feces and urine were 0.61 and 0.26, respectively. Absorbed doses for 188Re-liposo...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563462</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563462</guid>        </item>
        <item>
            <title>Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors</title>
            <link>http://www.medworm.com/index.php?rid=5563461&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001533%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: These results suggest that D2C7 warrants further evaluation for the development of MAb-based therapeutics against cancers expressing EGFRwt and EGFRvIII. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563461</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563461</guid>        </item>
        <item>
            <title>Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model</title>
            <link>http://www.medworm.com/index.php?rid=5563460&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001624%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Micrometastatic growth of an ovarian cancer cell line was reduced in nude mice after treatment with 213Bi-MX35or 211At-MX35. Treatment with 211At-MX35 provided a non-significantly better result for the chosen activity levels. The radiolabeled MX35 did not accumulate to a high extent in the investigated organs. No considerable signs of toxicity were observed. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563460</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563460</guid>        </item>
        <item>
            <title>Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors</title>
            <link>http://www.medworm.com/index.php?rid=5563459&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001545%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: 177Lu-h-R3 should be considered for further evaluations as a potential radiopharmaceutical for RIT of tumors overexpressing EGFR. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563459</comments>
            <pubDate>Wed, 28 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563459</guid>        </item>
        <item>
            <title>Synthesis and evaluation of 18F-labeled PPARγ antagonists</title>
            <link>http://www.medworm.com/index.php?rid=5563466&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001612%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The results of this preliminary study show that the irreversible antagonist [18F]3 may represent a novel strategy for imaging PPARγ in vivo with PET. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563466</comments>
            <pubDate>Mon, 12 Sep 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563466</guid>        </item>
        <item>
            <title>Important parameters to consider for the characterization of PET and SPECT imaging probes</title>
            <link>http://www.medworm.com/index.php?rid=5470923&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001478%2Fabstract%3Frss%3Dyes</link>
            <description>The Molecular Imaging and Contrast Agents Database (MICAD; http://www.micad.nih.gov) is mandated to provide freely accessible online information regarding molecular imaging probes and contrast agents (called tracer, probe or agent from here on) that are under development, in preclinical or clinical evaluation, or commercially available for clinical application . The primary aim of MICAD is to promote the discovery, development and application of molecular imaging in biology, drug discovery and the clinical sciences. For inclusion in MICAD, the primary consideration is that a molecular imaging probe should have in vivo animal or human studies published in peer-reviewed journals available on the PubMed database. A comprehensive search on PubMed showed there were ∼4500 imaging and contrast ...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470923</comments>
            <pubDate>Mon, 22 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470923</guid>        </item>
        <item>
            <title>The effects of chemical and radioactive properties of Tl-201 on human erythrocyte glutathione reductase activity</title>
            <link>http://www.medworm.com/index.php?rid=5563475&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001491%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: It was detected in in vitro and in vivo studies that the human erythrocyte GR enzyme is inhibited due to the radiation effect of 201Tl solution. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563475</comments>
            <pubDate>Wed, 10 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563475</guid>        </item>
        <item>
            <title>Synthesis and evaluation of PET probes for the imaging of I2 imidazoline receptors in peripheral tissues</title>
            <link>http://www.medworm.com/index.php?rid=5563467&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS096980511100148X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: [11C]Metrazoline may be a more useful PET probe than [11C]FTIMD for imaging of I2Rs in peripheral tissues. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563467</comments>
            <pubDate>Wed, 10 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563467</guid>        </item>
        <item>
            <title>Imaging of the muscarinic acetylcholine neuroreceptor in rats with the M2 selective agonist [18F]FP-TZTP</title>
            <link>http://www.medworm.com/index.php?rid=5563463&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001508%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Our results showed that the blood clearance and metabolism were too rapid to obtain a reproducible input function after bolus injection. The equilibrium distribution ratios did not lead to precise biochemical parameters, but the constant infusion was more suitable in that distribution ratios between tissue and plasma were statistically more precise. Constant infusion is the better approach for studying [18F]FP-TZTP by small animal imaging. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5563463</comments>
            <pubDate>Wed, 10 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5563463</guid>        </item>
        <item>
            <title>Nicotinic α4β2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3′-18F-fluoropropyl)pyridine (18F-nifzetidine)</title>
            <link>http://www.medworm.com/index.php?rid=5470936&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001235%2Fabstract%3Frss%3Dyes</link>
            <description>We report here the development of 3-(2-(S)-azetidinylmethoxy)-5-(3′-fluoropropyl)pyridine (nifzetidine) as a new putative high-affinity antagonist for nicotinic α4β2 receptors. Nifzetidine in rat brain homogenate assays containing α4β2 sites labeled with 3H-cytisine exhibited a binding affinity: Ki=0.67 nM. The fluorine-18 analog, 3-(2-(S)-azetidinylmethoxy)-5-(3′-18F-fluoropropyl)pyridine (18F-nifzetidine), was synthesized in 20%–40% yield, and apparent specific activity was estimated to be above 2 Ci/μmol. Rat brain slices indicated selective binding of 18F-nifzetidine to thalamus, subiculum, striata, cortex and other regions consistent with α4β2 receptor distribution. This selective binding was displaced &gt;85% by 150 μM nicotine. Positron emission tomography (PET) imaging s...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470936</comments>
            <pubDate>Wed, 10 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470936</guid>        </item>
        <item>
            <title>Early distribution of intravenously injected mesenchymal stem cells in rats with acute brain trauma evaluated by 99mTc-HMPAO labeling</title>
            <link>http://www.medworm.com/index.php?rid=5470935&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001284%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Early distribution of BMSCs in traumatic brain disease could be monitored by 99mTc-labeling, which does not induce cellular death. However, our data showed that the amount of migrated 99mTc-BMSCs was not enough to be demonstrated by clinical gamma camera. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470935</comments>
            <pubDate>Wed, 10 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470935</guid>        </item>
        <item>
            <title>New Ga derivatives of the H2dedpa scaffold with improved clearance and persistent heart uptake</title>
            <link>http://www.medworm.com/index.php?rid=5470934&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001223%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Recent advances in positron emission tomography (PET)/computed tomography have fueled the development of new PET-isotope-based agents for myocardial perfusion imaging. 68Ga, a generator-produced PET isotope, is an attractive radionuclide for developing a 68Ga-based cardiac imaging agent. We have synthesized seven new chelate systems based on our previously reported 1,2-[{6-(carboxylato-)pyridin-2-yl}methylamino]ethane (H2dedpa) scaffold. These ligands form lipophilic, cationic complexes upon coordination of 67/68Ga(III) under mild, direct labeling conditions within 10 min at room temperature. The corresponding cold complexes were also synthesized, and the solid-state structure of one of the complexes, [Ga(19)][ClO4], was determined. All compounds were investigated for in vitro st...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470934</comments>
            <pubDate>Wed, 10 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470934</guid>        </item>
        <item>
            <title>Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurements</title>
            <link>http://www.medworm.com/index.php?rid=5470932&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001296%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The scanning time of 90–100 min for 18F-AV-133 is considered as the optimal time window for summed uptake measurements in terms of SUVRs' correlation to DVRs, differential power, stability and clinical feasibility across and between NC and PD patients. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470932</comments>
            <pubDate>Wed, 10 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470932</guid>        </item>
        <item>
            <title>An automated SPE-based high-yield synthesis of [11C]acetate and [11C]palmitate: no liquid–liquid extraction, solvent evaporation or distillation required</title>
            <link>http://www.medworm.com/index.php?rid=5470930&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001259%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The method requires no liquid–liquid extraction, solvent evaporation or distillation capabilities and can be readily adapted to existing radiosynthesis modules. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470930</comments>
            <pubDate>Wed, 10 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470930</guid>        </item>
        <item>
            <title>Mass dose effects and in vivo affinity in brain PET receptor studies — a study of cerebral 5-HT4 receptor binding with [11C]SB207145</title>
            <link>http://www.medworm.com/index.php?rid=5470924&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS096980511100117X%2Fabstract%3Frss%3Dyes</link>
            <description>In this study, we devise a method for determining receptor occupancy of the mass dose of the radioligand itself and the in vivo affinity.Methods: The approach was used for [11C]SB207145, a new PET radioligand for imaging the cerebral 5-HT4 receptors in humans. Test–retest PET studies with varying specific activities of [11C]SB207145 were conducted in seven healthy subjects, and the output parameter regional BPND was modeled. Individual occupancy plots were first computed to estimate the mass dose that saturates 50% of receptors (ID50), and subsequently, the maximal mass dose that can be injected (arbitrarily set at an occupancy (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470924</comments>
            <pubDate>Wed, 10 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470924</guid>        </item>
        <item>
            <title>Reduced CGP12177 binding to cardiac β-adrenoceptors in hyperglycemic high-fat-diet-fed, streptozotocin-induced diabetic rats</title>
            <link>http://www.medworm.com/index.php?rid=5307270&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001120%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Reduced cardiac [3H]CGP12177 specific binding in the presence of sustained hyperglycemia corresponds to a decrease in relative β1-AR expression. These data indirectly support the use of [11C]CGP12177 for assessment of cardiac dysfunction in diabetes. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307270</comments>
            <pubDate>Wed, 10 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307270</guid>        </item>
        <item>
            <title>Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model</title>
            <link>http://www.medworm.com/index.php?rid=5307268&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001077%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: H3MN-16ET is a suitable tetradentate ligand for 188Re labeling. From the animal data, we suggest that 188Re-MN-16ET/Lipiodol has the potential to be a therapeutic radiopharmaceutical for hepatoma treatment. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307268</comments>
            <pubDate>Wed, 10 Aug 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307268</guid>        </item>
        <item>
            <title>Contents</title>
            <link>http://www.medworm.com/index.php?rid=5134760&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001685%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134760</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134760</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=5134741&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001648%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134741</comments>
            <pubDate>Sun, 31 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134741</guid>        </item>
        <item>
            <title>New radiosynthesis of 2-deoxy-2-[18F]fluoroacetamido-d-glucopyranose and its evaluation as a bacterial infections imaging agent</title>
            <link>http://www.medworm.com/index.php?rid=5134746&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000436%2Fabstract%3Frss%3Dyes</link>
            <description>In this study, we developed a new radiosynthesis method of 2-deoxy-2-[18F]fluoroacetamido-d-glucopyranose ([18F]FAG) by applying microwave irradiation and demonstrated that [18F]FAG could be a potential radiopharmaceutical to distinguish bacterial infection from nonbacterial inflammation.Methods: 1,3,4,6-Tetra-O-acetyl-2-deoxy-2-bromoacetamido-d-glucopyranose was used as precursor, and labeling was performed under microwave irradiation conditions followed by alkaline hydrolysis and high-performance liquid chromatography (HPLC) purification. In vitro uptake of [18F]FAG by Escherichia coli was performed. Tissue biodistribution of [18F]FAG was performed in mice. Moreover, PET imaging acquisition of E. coli infection and nonbacterial inflammation models was performed in rats. Tissue radiotrace...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134746</comments>
            <pubDate>Thu, 14 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134746</guid>        </item>
        <item>
            <title>Improved detection and measurement of low levels of [18F]fluoride metabolized from [18F]-labeled pyrimidine nucleoside analogues in biological samples</title>
            <link>http://www.medworm.com/index.php?rid=5470929&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001260%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Low levels of [18F]fluoride in biological samples can be detected and quantified using an ion-exchange cartridge and gamma counting. This methodology is simple, accurate and superior to the standard use of radio-HPLC on a C18 column for metabolite analysis, and it should be useful in pharmacokinetic modeling for animal imaging studies using an [18F]-labeled radiotracer and PET. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470929</comments>
            <pubDate>Mon, 11 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470929</guid>        </item>
        <item>
            <title>Effects of hypoxic–ischemic brain injury on striatal dopamine transporter in newborn piglets: evaluation of 11C-CFT PET/CT for DAT quantification</title>
            <link>http://www.medworm.com/index.php?rid=5470938&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001181%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Introduction: Alterations of dopamine in striatal presynaptic terminals play an important role in the hypoxic–ischemic (HI) brain injury. Quantification of DAT levels in the presynaptic site using 11C-N-2-carbomethoxy-3-(4-fluorophenyl)-tropane (11C-CFT) with positron emission tomography (PET) was applied in studies for Parkinson's disease. The current study investigated the changes in striatal DAT following HI brain injury in newborn piglets using 11C-CFT PET.Methods: Newborn piglets were subjected to occlusion of bilateral common carotid arteries for 30 min and simultaneous peripheral hypoxia. Brain DAT imaging was performed using PET/CT with 11C-CFT as the probe in each group (including the control group and HI insult groups). Brain tissues were collected for DAT immunohisto...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470938</comments>
            <pubDate>Fri, 08 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470938</guid>        </item>
        <item>
            <title>[18F]Fluoroazabenzoxazoles as potential amyloid plaque PET tracers: synthesis and in vivo evaluation in rhesus monkey</title>
            <link>http://www.medworm.com/index.php?rid=5470937&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001156%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: [18F]MK-3328 was identified as a promising PET tracer for in vivo quantification of amyloid plaques, and further evaluation in humans is warranted. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470937</comments>
            <pubDate>Fri, 08 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470937</guid>        </item>
        <item>
            <title>Three-dimensional quantitation of regional cerebral blood flow in mice using a high-resolution pinhole SPECT system and 123I-iodoamphetamine</title>
            <link>http://www.medworm.com/index.php?rid=5470933&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001211%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: This study demonstrated the feasibility of the 3D quantitation of rCBF in mice using a high-resolution pinhole SPECT system and 123I-IMP. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470933</comments>
            <pubDate>Fri, 08 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470933</guid>        </item>
        <item>
            <title>Improved quality control of [18F]fluoromethylcholine</title>
            <link>http://www.medworm.com/index.php?rid=5470931&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001247%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: An efficient and convenient GC method for the quality control of FCH has been developed and validated which meets all acceptance criteria in terms of linearity, specificity, precision, accuracy, LOD and LOQ. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470931</comments>
            <pubDate>Fri, 08 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470931</guid>        </item>
        <item>
            <title>Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody</title>
            <link>http://www.medworm.com/index.php?rid=5470928&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS096980511100120X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: This study demonstrates that the number of chelate conjugation and the injected dose are two important parameters to achieve high tumor and low non-target organ uptake of 111In-labeled MORAb-009. This study also suggests that the injected dose of mAb could be individualized based on the tumor size or the blood level of shed antigen in a patient to achieve the ideal tumor-to-organ radioactivity ratios. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470928</comments>
            <pubDate>Fri, 08 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470928</guid>        </item>
        <item>
            <title>The synthesis, magnetic purification and evaluation of 99mTc-labeled microbubbles</title>
            <link>http://www.medworm.com/index.php?rid=5470927&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001272%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: A convenient means to radiolabel and purify MBs was developed and the distribution of the labeled products determined. The result is a platform which can be used to assess the pharmacokinetics and fate of novel MB constructs both regionally using US and throughout the entire subject in a quantitative manner by employing small animal SPECT and tissue counting. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470927</comments>
            <pubDate>Fri, 08 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470927</guid>        </item>
        <item>
            <title>Development and validation of the 57Co assay for determining the ligand to antibody ratio in bifunctional chelate/antibody conjugates for use in radioimmunotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5470926&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001193%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: A detailed method for the 57Co ligand to antibody test is described that allows a discrete value to be obtained. The assay was validated as fit for purpose against target values of coefficient of variation (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470926</comments>
            <pubDate>Fri, 08 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470926</guid>        </item>
        <item>
            <title>Biodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2-fluorocyclopentyl-1-carboxylic acid</title>
            <link>http://www.medworm.com/index.php?rid=5307267&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001090%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Anti-2-[18F]FACPC-1 showed low background uptake in the brain, thoracic and abdominal cavities of humans, suggesting a possible use for detecting malignant tissues in these regions. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307267</comments>
            <pubDate>Fri, 08 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307267</guid>        </item>
        <item>
            <title>An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primate</title>
            <link>http://www.medworm.com/index.php?rid=5307255&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001119%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The cis-labeled [18F]mefway tracer has low specific binding throughout the 5-HT1A regions of the brain compared to trans-[18F]mefway, suggesting that the target-to-background binding of cis-[18F]mefway may limit its use for in vivo assessment of 5-HT1A binding. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307255</comments>
            <pubDate>Fri, 08 Jul 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307255</guid>        </item>
        <item>
            <title>Changes: choosing a target?</title>
            <link>http://www.medworm.com/index.php?rid=5134742&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005202%2Fabstract%3Frss%3Dyes</link>
            <description>“It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change.” Charles Darwin .  In 2001, Weissleder and Mahmood put forth this definition for Molecular Imaging: In contradistinction to classical (mostly anatomical) diagnostic imaging, it (molecular imaging) sets forth to probe the molecular abnormalities that are the basis of disease rather than to image the end effects of these molecular alterations. This brought into focus the contrast between what Nuclear Medicine had as a primary goal and what Radiology had as a primary goal, although functional studies with magnetic resonance imaging were being introduced at the time. This combination of strengths championed by Weissleder and Mahmood are illustrated by the proliferation of ...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134742</comments>
            <pubDate>Thu, 07 Jul 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134742</guid>        </item>
        <item>
            <title>Table of Contents</title>
            <link>http://www.medworm.com/index.php?rid=4979448&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001351%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979448</comments>
            <pubDate>Wed, 29 Jun 2011 23:52:34 +0100</pubDate>
            <guid isPermaLink="false">4979448</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=4979429&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001314%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979429</comments>
            <pubDate>Wed, 29 Jun 2011 23:52:26 +0100</pubDate>
            <guid isPermaLink="false">4979429</guid>        </item>
        <item>
            <title>Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 Affibody</title>
            <link>http://www.medworm.com/index.php?rid=5470925&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001168%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Radiolabeled ABY-025 Affibody molecule provides higher contrast in imaging of HER2-expressing PC xenografts than radiolabeled trastuzumab. Residualizing radiometal label for ABY-025 provides better contrast in imaging of HER2-expressing PC xenografts than nonresidualizing radiohalogen. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5470925</comments>
            <pubDate>Thu, 23 Jun 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5470925</guid>        </item>
        <item>
            <title>Sigma receptor binding of tetrabenazine series tracers targeting VMAT2 in rat pancreas</title>
            <link>http://www.medworm.com/index.php?rid=5307266&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001089%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: [18F]AV-133, in addition to a high-affinity VMAT2 binding site, binds with low affinity (but high capacity) to sigma components that are present in the rat pancreas. Identification of the cause of background binding of [18F]AV-133 to rat pancreatic tissue may lead to improved methods for quantification. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307266</comments>
            <pubDate>Thu, 23 Jun 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307266</guid>        </item>
        <item>
            <title>Rapid synthesis and in vitro and in vivo evaluation of folic acid derivatives labeled with fluorine-18 for PET imaging of folate receptor-positive tumors</title>
            <link>http://www.medworm.com/index.php?rid=5307265&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001065%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: In an attempt to visualize folate receptors that overexpress on many cancers, [18F]-fluorobenzene and pyridinecarbohydrazide-folate/methotrexate conjugates ([18F]-1, [18F]-2-folates and [18F]-8, [18F]-9-MTXs) were synthesized by the nucleophilic displacement reactions using ethyl-trimethylammonium-benzoate and pyridinecarboxylate precursors. The intermediates ethyl [18F]-fluorinated benzene and pyridine esters were reacted with hydrazine to produce the [18F]-fluorobenzene and pyridinecarbohydrazides, followed by coupling with N-hydroxysuccinimide-folate/MTX. Radiochemical yields were greater than 80% (decay corrected), with total synthesis time of less than 45 min. Radiochemical purities were always greater than 97% without high-performance liquid chromatography purification. The...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307265</comments>
            <pubDate>Thu, 23 Jun 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307265</guid>        </item>
        <item>
            <title>Evaluation of F-18-labeled 5-iodocytidine (18F-FIAC) as a new potential positron emission tomography probe for herpes simplex virus type 1 thymidine kinase imaging</title>
            <link>http://www.medworm.com/index.php?rid=5307262&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001144%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Our findings suggested that the cytidine analogue 18F-FIAC is a new potential PET probe for the imaging of HSV1-tk gene expression. 18F-FIAC may be regarded as the prodrug of 18F-FIAU in vivo. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307262</comments>
            <pubDate>Thu, 23 Jun 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307262</guid>        </item>
        <item>
            <title>The role of nucleoside/nucleotide transport and metabolism in the uptake and retention of 3′-fluoro-3′-deoxythymidine in human B-lymphoblast cells</title>
            <link>http://www.medworm.com/index.php?rid=5307261&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001132%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Initial rates of FLT uptake were a function of both concentrative and equilibrative transporters. TK1 activity was an absolute requirement for the accumulation of FLT. Retention was dependent on nucleoside/nucleotide efflux and retrograde metabolism of FLT nucleotides. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307261</comments>
            <pubDate>Thu, 23 Jun 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307261</guid>        </item>
        <item>
            <title>In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis</title>
            <link>http://www.medworm.com/index.php?rid=5307259&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001107%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The infusion of MSCs labeled with 111In-oxine through a peripheral vein is safe in cirrhosis. Cell labeling with 111In-oxine is a suitable method for tracking MSC distribution after infusion. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307259</comments>
            <pubDate>Thu, 23 Jun 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307259</guid>        </item>
        <item>
            <title>Development of new radiopharmaceuticals for imaging monoamine oxidase B</title>
            <link>http://www.medworm.com/index.php?rid=5307256&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111001053%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Introduction: Imaging monoamine oxidase B (MAO-B) in the central nervous system with PET is an important goal for psychiatric studies. We here report an improved and automated radiosynthesis of N-(6-[18F]-fluorohexyl)-N-methylpropargylamine ([18F]FHMP; [18F]-1), as well as the radiosynthesis of two new promising candidates for imaging cerebral MAO-B, namely, carbon-11-labeled 3-(4-[11C]-methoxyphenyl)-6-methyl-2H-1-benzopyran-2-one ([11C]-2) and N-((1H-pyrrol-2-yl)methyl)-N-[11C]-methyl-1-phenylmethanamine ([11C]-3).Methods: Fluorine-18-labeled 1 was prepared via a tosyloxy precursor in 29%±5% uncorrected radiochemical yield, relative to [18F]-fluoride. Both carbon-11-labeled compounds were prepared with [11C]CH3I using the “LOOP” method in 11% and 18% uncorrected radiochemi...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307256</comments>
            <pubDate>Mon, 20 Jun 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307256</guid>        </item>
        <item>
            <title>Postreperfusion myocardial technetium-99m–sestamibi defect corresponds to area at risk: Experimental results from an ischemia–reperfusion porcine model</title>
            <link>http://www.medworm.com/index.php?rid=5134747&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS096980511100045X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: In a porcine model of myocardial infarction after 45 min of ischemia, MIBI administered 120 min after reperfusion delineates AAR. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134747</comments>
            <pubDate>Thu, 19 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134747</guid>        </item>
        <item>
            <title>Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5307260&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000576%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Calculation of FES SUV, possibly adjusted for LBM, should be sufficient to assess FES uptake for the purpose of inferring ER expression. Pre-menopausal estradiol levels do not appear to interfere with FES uptake. The availability and binding properties of SHBG influence FES uptake and should be measured. Specific activity did not have a clear influence on FES uptake, except perhaps at higher injected mass per kilogram. These results suggest that FES imaging protocols may be simplified without sacrificing the validity of the results. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307260</comments>
            <pubDate>Fri, 06 May 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307260</guid>        </item>
        <item>
            <title>Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling</title>
            <link>http://www.medworm.com/index.php?rid=5134743&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000370%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Purpose: Unique uptake and retention mechanisms of positron emission tomography (PET) hypoxia tracers make in vivo comparison between them challenging. Differences in imaged uptake of two common hypoxia radiotracers, [61Cu]Cu-ATSM and [18F]FMISO, were characterized via computational modeling to address these challenges.Materials and Methods: An electrochemical formalism describing bioreductive retention mechanisms of these tracers under steady-state conditions was adopted to relate time-averaged activity concentration to tissue partial oxygen tension (PO2), a common metric of hypoxia. Chemical equilibrium constants of product concentration to reactant concentration ratios were determined from free energy changes and reduction potentials of pertinent reactions reported in the lite...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134743</comments>
            <pubDate>Thu, 05 May 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134743</guid>        </item>
        <item>
            <title>Table of Contents</title>
            <link>http://www.medworm.com/index.php?rid=4772949&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000849%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772949</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772949</guid>        </item>
        <item>
            <title>Binding of 2-[18F]fluoro-CP-118,954 to mouse acetylcholinesterase: microPET and ex vivo Cerenkov luminescence imaging studies</title>
            <link>http://www.medworm.com/index.php?rid=4772940&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004890%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Acetylcholinesterase (AChE) has been an important cholinergic factor for the diagnosis of Alzheimer's disease (AD), because of reduced AChE activity in the postmortem brains of AD patients. We previously developed 5,7-dihydro-3-(2-(1-(2-[18F]fluorobenzyl)-4-piperidinyl)ethyl)-6H-pyrrolo(3,2,f)-1,2-benzisoxazol-6-one (2-[18F]fluoro-CP-118,954) for in vivo studies of AChE in mice. In the present study, we automated the synthesis of 2-[18F]fluoro-CP-118,954 for the routine use and evaluated the radioligand by microPET and ex vivo Cerenkov luminescence imaging of mouse AChE. 4-[18F]Fluoro-donepezil, another AChE inhibitor, was used for comparison. Automated syntheses of 2-[18F]fluoro-CP-118,954 and 4-[18F]fluoro-donepezil resulted in high radiochemical yields (25–33% and 30–40%) ...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772940</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772940</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=4772930&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000801%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772930</comments>
            <pubDate>Sat, 30 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772930</guid>        </item>
        <item>
            <title>Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice</title>
            <link>http://www.medworm.com/index.php?rid=5307258&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000552%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Consistent with biodistribution studies, uptake of [18F]-scyllo-inositol was successfully visualized by PET imaging in human BC and glioma xenografts, with lower accumulation in inflammatory tissue than [18F]-FDG. The tumour-to-brain ratio of [18F]-scyllo-inositol was also significantly higher than that of [18F]-FDG for visualizing intracranial glioma xenografts in NOD SCID mice, giving a better contrast.Graphical Abstract: (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307258</comments>
            <pubDate>Fri, 29 Apr 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307258</guid>        </item>
        <item>
            <title>Cyclotron production of 99mTc: Experimental measurement of the 100Mo(p,x)99Mo, 99mTc and 99gTc excitation functions from 8 to 18 MeV</title>
            <link>http://www.medworm.com/index.php?rid=5134758&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000473%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: These findings suggest that the cyclotron production of 99mTc may be a feasible alternative to the current reactor-based production strategy. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134758</comments>
            <pubDate>Thu, 28 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134758</guid>        </item>
        <item>
            <title>Preparation and biological evaluation of 177Lu conjugated PR81 for radioimmunotherapy of breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=5134752&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000461%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The results showed that one may consider 177Lu-DOTA–PR81 as a potential radiopharmaceutical for therapy of human breast cancer, which needs further investigations. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134752</comments>
            <pubDate>Thu, 28 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134752</guid>        </item>
        <item>
            <title>Simplified quantification of FDG metabolism in tumors using the autoradiographic method is less dependent on the acquisition time than SUV</title>
            <link>http://www.medworm.com/index.php?rid=5134750&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000400%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Compared to the SUV, the autoradiographic Ki values are advantageous for various reasons. First, they are much less dependent on the time of acquisition than the SUV. Second, their calculation does not require the knowledge of the body weight or the injected activity. Furthermore, the values are comparable to the ones obtained with the widely accepted Patlak method. The method can be easily implemented in a clinical setting, as it uses only one static scan. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134750</comments>
            <pubDate>Thu, 28 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134750</guid>        </item>
        <item>
            <title>Auger electron emitter against multiple myeloma — targeted endo-radio-therapy with 125I-labeled thymidine analogue 5-iodo-4′-thio-2′-deoxyuridine</title>
            <link>http://www.medworm.com/index.php?rid=5307271&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000564%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: These studies may provide a novel treatment strategy for overcoming resistance to conventional therapy in multiple myeloma. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307271</comments>
            <pubDate>Fri, 22 Apr 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307271</guid>        </item>
        <item>
            <title>Dedifferentiation of differentiated thyroid carcinoma cell line FTC-133 is enhanced by 131I pretreatment</title>
            <link>http://www.medworm.com/index.php?rid=5307269&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000540%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Introduction: Differentiated thyroid carcinoma (DTC) usually has a high iodine uptake. However, dedifferentiation of DTC with decreased or no radioiodine (131I) uptake is observed in clinical practice, with poor prognosis. The aim of this study was to investigate the effects of 131I radiation on radioiodine uptake (RAIU) and the expression of thyroid-specific molecules.Methods: FTC-133 cells were treated with 131I, the dosage dictated by methylthiazol tetrazolium test results and preliminary experiments. The experimental cell group was incubated with 131I for 48 h and then cultured for 3 months in 131I-free medium. The control group was set without 131I. Primary cells were defined as the blank group. Following treatment, RAIU was measured with a gamma counter as the counts/cell n...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307269</comments>
            <pubDate>Fri, 22 Apr 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307269</guid>        </item>
        <item>
            <title>Synthesis and evaluation of a novel 68Ga-chelate-conjugated bisphosphonate as a bone-seeking agent for PET imaging</title>
            <link>http://www.medworm.com/index.php?rid=5307264&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000527%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: We have developed a novel 68Ga-radiolabeled bone-seeking agent. This [68Ga]NOTA-BP complex was found to have a high bone affinity and rapid blood clearance, and may thus prove to be useful as a bone-seeking agent for clinical PET. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307264</comments>
            <pubDate>Fri, 22 Apr 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307264</guid>        </item>
        <item>
            <title>PEGylation of 99mTc-labeled bombesin analogues improves their pharmacokinetic properties</title>
            <link>http://www.medworm.com/index.php?rid=5307263&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000515%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Introduction: Radiolabeled bombesin (BN) conjugates are promising radiotracers for imaging and therapy of breast and prostate tumors in which BN2/gastrin-releasing peptide (GRP) receptors are overexpressed. However, the low in vivo stability of BN conjugates may limit their clinical application. In an attempt to improve their pharmacokinetics and counteract their rapid enzymatic degradation, we prepared a series of polyethylene glycol (PEG)-ylated BN(7-14) analogues for radiolabeling with 99mTc(CO)3 and evaluated them in vitro and in vivo.Methods: Derivatization of a stabilized (NαHis)Ac-BN(7-14)[Cha13,Nle14] analogue with linear PEG molecules of various sizes [5 kDa (PEG5), 10 kDa (PEG10) and 20 kDa (PEG20)] was performed by PEGylation of the ɛ-amino group of a β3hLys-βAla-...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307263</comments>
            <pubDate>Fri, 22 Apr 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307263</guid>        </item>
        <item>
            <title>Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET</title>
            <link>http://www.medworm.com/index.php?rid=5307257&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000539%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Introduction: To clarify the role of oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson's disease (PD) in living patients, positron emission tomography (PET) with [62Cu]diacetyl-bis(N4-methylthiosemicarbazone) ([62Cu]ATSM) was applied to functional imaging of oxidative stress mainly due to mitochondrial dysfunction in the striata of patients with PD.Methods: Fifteen PD patients who presented with lateral dominant symptoms at onset and six healthy controls underwent [62Cu]ATSM PET. Dynamic PET data acquisition was performed, and standardized uptake values (SUVs) were obtained from the delayed phase of dynamic data by means of region of interest analysis. The striatum-to-cerebellum SUV ratio (S/C ratio) was calculated from the SUV in all subjects of the...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5307257</comments>
            <pubDate>Fri, 22 Apr 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5307257</guid>        </item>
        <item>
            <title>Evaluation of 111In labeled antibodies for SPECT imaging of mesothelin expressing tumors</title>
            <link>http://www.medworm.com/index.php?rid=5134756&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000503%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: SPECT imaging of mesothelin expressing tumors was demonstrated successfully. Our findings indicate that the antimesothelin antibody mAbMB has the potential to be developed into a diagnostic agent for imaging mesothelin-expressing cancers. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134756</comments>
            <pubDate>Thu, 21 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134756</guid>        </item>
        <item>
            <title>Characterization of iodinated adrenomedullin derivatives suitable for lung nuclear medicine</title>
            <link>http://www.medworm.com/index.php?rid=5134754&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000394%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: These results emphasize the fact that even a small chemical modification, i.e. iodination, might deeply modify the pharmacological profile of a compound and support observations that the C-terminal tail of human AM plays an important role in the AM receptor binding process. Consequently, incorporation of a radionuclide to produce an AM-based nuclear medicine agent should privilege the N-terminus of the molecule. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134754</comments>
            <pubDate>Thu, 21 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134754</guid>        </item>
        <item>
            <title>Preparation and biological evaluation of 3-[76Br]bromo-α-methyl-l-tyrosine, a novel tyrosine analog for positron emission tomography imaging of tumors</title>
            <link>http://www.medworm.com/index.php?rid=5134753&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000369%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: [77Br]BAMT showed high levels of tumor accumulation, and [76Br]BAMT enabled clear visualization of the tumor by PET imaging. Although an improvement in stability is still needed, 76Br-labeled FAMT analogs could potentially serve as PET tracers for the imaging of malignant tumors. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134753</comments>
            <pubDate>Thu, 21 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134753</guid>        </item>
        <item>
            <title>Improving the quantitation accuracy in noninvasive small animal single photon emission computed tomography imaging</title>
            <link>http://www.medworm.com/index.php?rid=5134751&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000412%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: In this study, the discrepancy in quantitating organ radioactivity accumulations between noninvasive imaging and necropsy was primarily due to blood pool radioactivity contributing to the in vivo images. The discrepancy may be minimized by subtracting an estimate of this contribution. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134751</comments>
            <pubDate>Thu, 21 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134751</guid>        </item>
        <item>
            <title>Distribution of adoptively transferred porcine T-lymphoblasts tracked by 18F-2-fluoro-2-deoxy-d-glucose and position emission tomography</title>
            <link>http://www.medworm.com/index.php?rid=5134748&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000485%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The present work shows the feasibility of quantitatively monitoring and evaluating cell trafficking and distribution following administration of [18F]FDG-labeled T-lymphoblasts. The protocol can potentially be transferred to the clinical setting with few modifications. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134748</comments>
            <pubDate>Thu, 21 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134748</guid>        </item>
        <item>
            <title>A 99mTc-labeled dual-domain cytokine ligand for imaging of inflammation</title>
            <link>http://www.medworm.com/index.php?rid=5134745&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000497%2Fabstract%3Frss%3Dyes</link>
            <description>This study was designed to 99mTc-radiolabel an IL-1ra and IL-18bp dual-domain cytokine ligand, IL-18bp-Fc-IL-1ra, for specific inflammation targeting.Methods: The 99mTc-IL-18bp-Fc-IL-1ra was obtained by direct labeling via 2-iminothiolane reduction. Competitive binding of 99mTc-labeled and unlabeled IL-18bp-Fc-IL-1ra to rat polymorphonuclear leukocytes was assessed in vitro. A mouse ear edema model was used to evaluate specific targeting properties of 99mTc-IL-18bp-Fc-IL1ra in vivo. The correlation between 99mTc-IL-18bp-Fc-IL-1ra uptake and 111In-labeled polymorphonuclear neutrophil infiltration was studied using ischemic–reperfused rat hearts.Results: Direct 99mTc-labeling yielded a stable dual-domain cytokine radioligand with radiochemical purity greater than 95% after gel filtration. ...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134745</comments>
            <pubDate>Thu, 21 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134745</guid>        </item>
        <item>
            <title>Complementary information from magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model</title>
            <link>http://www.medworm.com/index.php?rid=5134744&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000382%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: We propose that [18F]-FMISO PET and multiparametric magnetic resonance imaging are pertinent complementary tools in the evaluation of the effects of an antiangiogenic treatment in glioma. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134744</comments>
            <pubDate>Thu, 21 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134744</guid>        </item>
        <item>
            <title>The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy</title>
            <link>http://www.medworm.com/index.php?rid=5134759&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000448%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: We were able to produce 161Tb in n.c.a. form by irradiating highly enriched 160Gd targets; it can be obtained in the quantity and quality required for the preparation of 161Tb-labeled therapeutic agents. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134759</comments>
            <pubDate>Wed, 20 Apr 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134759</guid>        </item>
        <item>
            <title>Table of Contents</title>
            <link>http://www.medworm.com/index.php?rid=4706638&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000655%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706638</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4706638</guid>        </item>
        <item>
            <title>[18F]FE@SUPPY and [18F]FE@SUPPY:2 — metabolic considerations</title>
            <link>http://www.medworm.com/index.php?rid=4706637&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000333%2Fabstract%3Frss%3Dyes</link>
            <description>The contribution of Prof. Spreitzer for the article above was the participation in the planning of the project and the supervision of the precursor preparation. Additionally, the correct byline appears above. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706637</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4706637</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=4706620&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000618%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706620</comments>
            <pubDate>Thu, 31 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4706620</guid>        </item>
        <item>
            <title>Striatal adenosine A2A receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [18F]-MRS5425</title>
            <link>http://www.medworm.com/index.php?rid=5134757&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000357%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Thus, increase of A2A receptor-mediated uptake of radioactive MRS5425 could be a superior molecular target for Parkinson's imaging. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134757</comments>
            <pubDate>Wed, 30 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134757</guid>        </item>
        <item>
            <title>Radiosynthesis and in vivo evaluation of [11C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A</title>
            <link>http://www.medworm.com/index.php?rid=5134755&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000424%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: We demonstrated that [11C]MP-10 possesses good characteristics for the in vivo quantification of the PDE10A in the brain by PET. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5134755</comments>
            <pubDate>Wed, 30 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5134755</guid>        </item>
        <item>
            <title>99mTc-technetium labeling of antiarthritic peptides to evaluate homing and biodistribution at inflamed joints</title>
            <link>http://www.medworm.com/index.php?rid=4979446&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000321%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: This study highlights the versatility of using the His derivative linker for 99mTc tagging of a variety of peptides. It also demonstrates greater peptide localization and thereby bioavailability of therapeutic peptides to inflamed joints following specific conjugation to homing peptides. The ability to localize peptide/drugs to inflamed synovium has important therapeutic implications. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979446</comments>
            <pubDate>Wed, 30 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979446</guid>        </item>
        <item>
            <title>Correlative single photon emission computed tomography imaging of [123I]altropane binding in the rat model of Parkinson's</title>
            <link>http://www.medworm.com/index.php?rid=4979445&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005147%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Our data reveal that [123I]altropane predicts the integrity of the striatal dopamine nerve terminals, but does not predict the integrity of the nigrostriatal system. [123I]altropane could be a useful marker to measure dopamine content in cell replacement therapies; however, it would not be able to evaluate outcomes for neuroprotective strategies. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979445</comments>
            <pubDate>Wed, 30 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979445</guid>        </item>
        <item>
            <title>The improved syntheses of 5-substituted 2′-[18F]fluoro-2′-deoxy-arabinofuranosyluracil derivatives ([18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU) using a multistep one-pot strategy</title>
            <link>http://www.medworm.com/index.php?rid=4979437&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000047%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The improved radiosyntheses of [18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU have been achieved with reasonable yields and high purity using a multistep one-pot method. The synthetic time has been reduced, and the reaction procedures have been significantly simplified. The success of this approach may make PET tracers [18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU more accessible for preclinical and clinical research. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979437</comments>
            <pubDate>Wed, 30 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979437</guid>        </item>
        <item>
            <title>Synthesis of O-(2-[18F]fluoroethyl)-l-tyrosine based on a cartridge purification method</title>
            <link>http://www.medworm.com/index.php?rid=4979436&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS096980511100031X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: We present a radiosynthesis of FET where the usually used HPLC purification procedure has been substituted by a purification step based on standard cartridges. This method is useful for automatic modules without an expensive HPLC purification unit and for the routine production of FET. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979436</comments>
            <pubDate>Wed, 30 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979436</guid>        </item>
        <item>
            <title>Dose-on-demand of diverse 18F-fluorocholine derivatives through a two-step microfluidic approach</title>
            <link>http://www.medworm.com/index.php?rid=4979434&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000308%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The described approach gives a proof of principle of the enhanced productivity obtainable using a microfluidic approach; in particular, the possibility to produce the reported tracers in a DOD fashion following a homogeneous synthetic and purification approach will foster further studies on the clinical evaluation of the best fluorocholine analogue for prostate cancer imaging without biasing for differences in radiochemical approach. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979434</comments>
            <pubDate>Wed, 30 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979434</guid>        </item>
        <item>
            <title>Radiopharmaceutical considerations on bone seeker uptake: should we learn from therapeutical targets of bisphosphonates?</title>
            <link>http://www.medworm.com/index.php?rid=4979431&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000291%2Fabstract%3Frss%3Dyes</link>
            <description>Although bone seekers have been used for more than 30 years in nuclear medicine, the underlying mechanisms involved in their uptake into osseous tissue are still under discussion. Controversial hypotheses regarding these mechanisms range from simple chemisorption onto bone minerals with disputed binding to the organic collagen phase, overincorporation into the mineralisation process, to a combination of both mechanisms. Additionally, the involvement of the cellular fraction of bone tissue has been a matter of discussion. Recently, discussion has intensified on the involvement of osteoclasts in this uptake process. Comprehensible arguments that underline the contribution of osteoclasts originate from research on bisphosphonates (BPs) in antiresorptive therapy (e.g., in osteoporosis, Morbus ...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979431</comments>
            <pubDate>Wed, 30 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979431</guid>        </item>
        <item>
            <title>Review of new clinical applications of radiometal labeled radiopharmaceuticals</title>
            <link>http://www.medworm.com/index.php?rid=4979430&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005196%2Fabstract%3Frss%3Dyes</link>
            <description>Contributions from Matthias Friebe, Ph.D., of Bayer Healthcare, Peter Iveson, Ph.D., of General Electric, John Babich, Ph.D., of Molecular Insight Pharmaceuticals, Inc., Frederick Cope of Neoprobe Corporation and Roberto Pasquilini of IBA. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979430</comments>
            <pubDate>Wed, 30 Mar 2011 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979430</guid>        </item>
        <item>
            <title>Radiochemotherapy of hepatocarcinoma via lentivirus–mediated transfer of human sodium iodide symporter gene and herpes simplex virus thymidine kinase gene</title>
            <link>http://www.medworm.com/index.php?rid=4979447&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005184%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: We demonstrate that radiochemotherapy of hepatocarcinoma via lentiviral-mediated coexpression of NIS gene and HSV-TK gene leads to stronger killing effect than single treatment, and in vivo studies are needed to verify these findings. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979447</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979447</guid>        </item>
        <item>
            <title>Effect of cyclosporin A on the uptake of D3-selective PET radiotracers in rat brain</title>
            <link>http://www.medworm.com/index.php?rid=4979444&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000035%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: These data suggest that D3 selective conformationally-flexible benzamide analogs which contain a N-2-methoxyphenylpiperazine moiety are substrates for P-glycoprotein or other adenosine triphosphate (ATP)-binding cassette transporters expressed at the blood-brain barrier, and that PET radiotracers containing this pharmacophore may display low brain uptake in rodents due to the action of these efflux transporters. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979444</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979444</guid>        </item>
        <item>
            <title>Tumor targeting using 67Ga-DOTA-Bz-folate — investigations of methods to improve the tissue distribution of radiofolates</title>
            <link>http://www.medworm.com/index.php?rid=4979443&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005238%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Introduction: Use of folic acid radioconjugates for folate receptor (FR) targeting is a promising strategy for imaging purposes as well as for potential therapy of cancer and inflammatory diseases due to the frequent FR overexpression found on cancer cells and activated macrophages. Herein, we report on preclinical results using a novel DOTA-Bz-EDA-folate conjugate radiolabeled with [67Ga]-gallium.Methods: DOTA-Bz-EDA-folate was prepared by conjugation of ethylenediamine-(γ)-folate with 2-(p-isothiocyanobenzyl)-DOTA. Radiolabeling was carried out with 67GaCl3 according to standard procedures. Biodistribution studies of the tracer were performed in mice bearing FR-positive KB tumor xenografts. The effects on radiofolate biodistribution with coadministered renal uptake-blocking am...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979443</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979443</guid>        </item>
        <item>
            <title>Evaluation of the P-glycoprotein- and breast cancer resistance protein-mediated brain penetration of 11C-labeled topotecan using small-animal positron emission tomography</title>
            <link>http://www.medworm.com/index.php?rid=4979442&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005226%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: We demonstrated the increase of brain penetration of [11C]TPT by deficiency and inhibition of Pgp and BCRP functions using small-animal PET in mice. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979442</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979442</guid>        </item>
        <item>
            <title>Influence of an aliphatic linker between DOTA and synthetic ZHER2:342 Affibody molecule on targeting properties of the 111In-labeled conjugate</title>
            <link>http://www.medworm.com/index.php?rid=4979441&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005172%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: A 6-aminohexanoic linker between the DOTA chelator and N-terminus of synthetic ZHER2:342 had a measurable effect on affinity, cellular retention of radioactivity and blood clearance. The linker might be used for modulation of targeting properties of Affibody molecules. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979441</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979441</guid>        </item>
        <item>
            <title>The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), A PET radiotracer designed for the delineation of histone deacetylase expression in cancer</title>
            <link>http://www.medworm.com/index.php?rid=4979440&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005160%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The significant non-tumor background uptake of [18F]-FESAHA presents a substantial obstacle to the use of the radiotracer as an HDAC expression imaging agent. The study at hand, however, does present a number of lessons critical to both the synthesis of hydroxamic acid containing PET radiotracers and imaging agents aimed at delineating HDAC expression. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979440</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979440</guid>        </item>
        <item>
            <title>In vivo biodistribution and accumulation of 89Zr in mice</title>
            <link>http://www.medworm.com/index.php?rid=4979439&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005214%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Despite the complexity of Zr coordination, the electrophoretic analyses provided detailed evidences of Zr charges either as salts or as complexes. This study also shows that weakly chelated, 89Zr is a bone seeker and has a strong affinity for phosphate. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979439</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979439</guid>        </item>
        <item>
            <title>Analysis of metabolism of 6FDG: a PET glucose transport tracer</title>
            <link>http://www.medworm.com/index.php?rid=4979438&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005159%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: On the time scale typical of PET imaging studies radioactive metabolites of [18F]6FDG are negligible. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979438</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979438</guid>        </item>
        <item>
            <title>Fully automated one-pot radiosynthesis of O-(2-[18F]fluoroethyl)-l-tyrosine on the TracerLab FXFN module</title>
            <link>http://www.medworm.com/index.php?rid=4979435&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000023%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The automated radiosynthesis provides high and reproducible yields suitable for routine clinical use. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979435</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979435</guid>        </item>
        <item>
            <title>Preparation and evaluation of a radiogallium complex-conjugated bisphosphonate as a bone scintigraphy agent</title>
            <link>http://www.medworm.com/index.php?rid=4979433&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005123%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: 67Ga-DOTA-Bn-SCN-HBP showed ideal biodistribution characteristics as a bone-imaging agent. These findings should provide useful information on the drug design of bone imaging agents for PET with 68Ga. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979433</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979433</guid>        </item>
        <item>
            <title>Preparation and in vivo biological investigations on a novel radioligand for bone scanning: technetium-99m-labeled zoledronic acid derivative</title>
            <link>http://www.medworm.com/index.php?rid=4979432&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005135%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: 99mTc-IPrDP possesses excellent characteristics for the potential application as a novel bone scanning agent. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4979432</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4979432</guid>        </item>
        <item>
            <title>New automated synthesis of [18F]FP-CIT with base amount control affording high and stable radiochemical yield: a 1.5-year production report</title>
            <link>http://www.medworm.com/index.php?rid=4772946&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004919%2Fabstract%3Frss%3Dyes</link>
            <description>We describe new [18F]Fluoropropylcarbomethoxyiodophenyl-nor-tropane ([18F]FP-CIT) automatic preparation method by (1) using 2-methyl-2-butanol as [18F]fluorination solvent, (2) base amount control to minimize side reaction and (3) salt elution method to elute trapped [18F]fluoride. We developed manual synthesis procedures for automatic synthesis application. In this manual synthesis, we trapped [18F]F− on ion exchange cartridge and eluted with 0.2 M potassium methanesulfonate solution. We have [18F]fluorination at 100°C with 2-methyl-2-butanol as protic solvent for [18F]fluorination. After high-performance liquid chromatography analysis, we have 69.3±3.2% of [18F]F− incorporation ratio on the manual synthesis and applied these conditions to automatic preparation with GE TracerLab FX ...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772946</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772946</guid>        </item>
        <item>
            <title>Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3′deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging</title>
            <link>http://www.medworm.com/index.php?rid=4772934&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005111%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: An increasing trend between 18FLT uptake and Ki67 mitotic index is seen in malignant tissue. Additional studies will determine whether 18FLT PET/CT is specific enough to distinguish between cancerous and noncancerous cells and to assess its role in ovarian carcinoma patient management. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772934</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772934</guid>        </item>
        <item>
            <title>Validation of an amino-acid-based radionuclide therapy plus external beam radiotherapy in heterotopic glioblastoma models</title>
            <link>http://www.medworm.com/index.php?rid=4772931&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS096980511000510X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: These preclinical data convincingly demonstrated that [131I]IPA plus external beam photon radiotherapy is a safe and highly effective treatment for experimental gliomas, which may merit a clinical trial to ascertain its potential as a therapeutic approach in patients. As only a low [131I]IPA activity and a low RT dose were applied, further optimization strategies should be pursued experimentally, including application of higher radiation doses and conventional fractionated regimens or use of methods aiming to increase target doses and maximize dose effects. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772931</comments>
            <pubDate>Mon, 07 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772931</guid>        </item>
        <item>
            <title>Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer</title>
            <link>http://www.medworm.com/index.php?rid=4772937&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004828%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Our results indicate that, despite its rapid metabolism, [18F]FBA-FALGEA-NH2 binds preferentially to EGFRvIII in the tumours in vivo and is a promising lead for further development of EGFRvIII specific peptide radiopharmaceuticals. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772937</comments>
            <pubDate>Wed, 02 Mar 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772937</guid>        </item>
        <item>
            <title>Feasibility of a novel positive feedback effect of 131I-promoted Bac-Egr1-hNIS expression in malignant glioma via baculovirus</title>
            <link>http://www.medworm.com/index.php?rid=4772947&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004841%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Our results indicated that an improved transgene expression of 131I-stimulated hNIS in U87 cells using a baculovirus vector containing the Egr1 promoter is possible, and the increased expression of hNIS is responsible for a higher 131I uptake. It might provide a reference for the existence of a positive feedback effect in 131I-promoted Bac-Egr1-hNIS expression in malignant glioma and is an interesting aspect of NIS-related studies. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772947</comments>
            <pubDate>Tue, 08 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772947</guid>        </item>
        <item>
            <title>Development of a nano-zirconia based 68Ge/68Ga generator for biomedical applications</title>
            <link>http://www.medworm.com/index.php?rid=4772944&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004774%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Introduction: Most of the commercially available 68Ge/68Ga generator systems are not optimally designed for direct applications in a clinical context. We have developed a nano-zirconia based 68Ge/68Ga generator system for accessing 68Ga amenable for the preparation of radiopharmaceuticals.Methods: Nano-zirconia was synthesized by the in situ reaction of zirconyl chloride with ammonium hydroxide in alkaline medium. The physical characteristics of the material were studied by various analytical techniques. A 740 MBq (20 mCi) 68Ge/68Ga generator was developed using this sorbent and its performance was evaluated for a period of 1 year. The suitability of 68Ga for labeling biomolecules was ascertained by labeling DOTA-TATE with 68Ga.Results: The material synthesized was nanocrystallin...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772944</comments>
            <pubDate>Tue, 08 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772944</guid>        </item>
        <item>
            <title>Synthesis and in vitro/in vivo evaluation of 99mTc-labeled folate conjugates for folate receptor imaging</title>
            <link>http://www.medworm.com/index.php?rid=4772942&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004865%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The modification of the coligands can significantly alter the pharmacokinetic properties of the corresponding 99mTc-HYNIC complexes. 99mTc (HYNIC-NHHN-FA)(tricine/TPPTS), 7 could be a promising radiotracer for FR imaging. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772942</comments>
            <pubDate>Tue, 08 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772942</guid>        </item>
        <item>
            <title>Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4</title>
            <link>http://www.medworm.com/index.php?rid=4772939&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004877%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Introduction: The αVβ3 integrin is a well-known transmembrane receptor involved in tumor invasion, angiogenesis and metastasis. Our aim was to evaluate a novel positron emission tomography (PET) probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4, for noninvasive visualization and quantification of αVβ3 integrin expression.Methods: RAFT-c(-RGDfK-)4, a tetrameric cyclic Arg-Gly-Asp (RGD)-based peptide, was conjugated with a bifunctional chelator, 1,4,8,11-tetraazacyclotetradecane (cyclam), radiolabeled with the positron emitter 64Cu and evaluated in vitro by cell binding and competitive inhibition assays and in vivo by biodistribution and receptor blocking studies, and PET imaging. The following cell lines, human embryonic kidney HEK293(β1) [αVβ3-negative] and HEK293(β3) [αVβ3-overexpre...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772939</comments>
            <pubDate>Tue, 08 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772939</guid>        </item>
        <item>
            <title>In vivo evaluation of carbon-11-labelled non-sarcosine-based glycine transporter 1 inhibitors in mice and conscious monkeys</title>
            <link>http://www.medworm.com/index.php?rid=4772938&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004889%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: [11C]SA1 has the most suitable profile among the three carbon-11-labelled GlyT-1 inhibitors. Lead optimization of [11C]SA1 structure will be required to achieve in vivo selective GlyT-1 imaging. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772938</comments>
            <pubDate>Tue, 08 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772938</guid>        </item>
        <item>
            <title>Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging</title>
            <link>http://www.medworm.com/index.php?rid=4772936&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004804%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: In this research, two new fluorine-18 labeled 2-nitroimidazole derivatives, [18F]7 and [18F]8, both of which containing in vivo hydrolyzable group, were successfully prepared. Further biological evaluations are warranted to investigate their potential as PET radioligands for imaging tumor. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772936</comments>
            <pubDate>Tue, 08 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772936</guid>        </item>
        <item>
            <title>Development of the radiosynthesis of high-specific-activity 123I-NKJ64</title>
            <link>http://www.medworm.com/index.php?rid=4772935&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004907%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: The radiosynthesis of 123I-NKJ64 was achieved with good isolated radiochemical yield of 68% and a high specific activity of 1.8 Ci/μmol. TFA was found to be the most suitable deprotecting agent, since 2 M HCl generated a by-product that could not be fully separated from 123I-NKJ64 using the HPLC methodology investigated. This study highlights the importance of HPLC purification and accurate measurement of specific activity while developing new radiosynthesis methodologies. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772935</comments>
            <pubDate>Tue, 08 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772935</guid>        </item>
        <item>
            <title>Nucleophilic radiosynthesis of 2-[18F]fluoro-2-deoxy-d-galactose from Talose triflate and biodistribution in a porcine model</title>
            <link>http://www.medworm.com/index.php?rid=4772933&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004853%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Commercially available Talose triflate is a suitable starting material for routine productions of FDGal. The presented radiosynthesis and quality control methods allow for the production of pure, no-carrier-added FDGal in sufficient amounts for clinical PET-investigations of the liver. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772933</comments>
            <pubDate>Tue, 08 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772933</guid>        </item>
        <item>
            <title>Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-d-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=4772932&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS096980511000483X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Based on the GLUT5 specific transport and phosphorylation by ketohexokinase, 6-[18F]FDF may represent a novel radiotracer for PET imaging of GLUT5 and ketohexokinase-expressing tumors. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772932</comments>
            <pubDate>Tue, 08 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772932</guid>        </item>
        <item>
            <title>Table of Contents and Barcode</title>
            <link>http://www.medworm.com/index.php?rid=4467796&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000102%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4467796</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4467796</guid>        </item>
        <item>
            <title>Editorial</title>
            <link>http://www.medworm.com/index.php?rid=4467777&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110005093%2Fabstract%3Frss%3Dyes</link>
            <description>The editorial board of Nuclear Medicine and Biology would like to wish you a belated Happy New Year and thank you for your support of the journal over the past year.  To start this new year, we have altered the cover of Nuclear Medicine and Biology and the aims and scope to better reflect the goals of the journal. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4467777</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4467777</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=4467776&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805111000060%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4467776</comments>
            <pubDate>Tue, 01 Feb 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4467776</guid>        </item>
        <item>
            <title>In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue</title>
            <link>http://www.medworm.com/index.php?rid=4467792&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004105%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Our studies demonstrate that as opposed to its behavior in human recombinant system, in rat brain tissue CUMI-101 behaves as a potent 5-HT1A receptor antagonist. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4467792</comments>
            <pubDate>Mon, 03 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4467792</guid>        </item>
        <item>
            <title>Table of Contents and Barcode</title>
            <link>http://www.medworm.com/index.php?rid=4366210&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS096980511000497X%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4366210</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4366210</guid>        </item>
        <item>
            <title>Radiolabeling of rituximab with 188Re and 99mTc using the tricarbonyl technology</title>
            <link>http://www.medworm.com/index.php?rid=4366198&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110003896%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Rituximab could be directly and stably labeled with the matched pair 99mTc/188Re using the IsoLink technology under retention of the biological activity. Labeling kinetics and yields need further improvement for potential routine application in radioimmunodiagnosis and therapy. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4366198</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4366198</guid>        </item>
        <item>
            <title>Editorial Board</title>
            <link>http://www.medworm.com/index.php?rid=4366195&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004932%2Fabstract%3Frss%3Dyes</link>
            <description>(Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4366195</comments>
            <pubDate>Sat, 01 Jan 2011 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4366195</guid>        </item>
        <item>
            <title>Development and validation of an anion-exchange HPLC method for the determination of fluoride content and radiochemical purity in [18F]NaF</title>
            <link>http://www.medworm.com/index.php?rid=4772948&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004786%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: 18F-labeled sodium fluoride ([18F]NaF) is a useful bone imaging agent that has been demonstrated to be significantly more accurate than 99mTc-labeled methylene diphosphonate for the detection of both sclerotic and lytic lesions in various malignancies. A reliable anion-exchange HPLC method equipped with suppressed conductivity and radioactive detectors has been developed in order to analyze the content of NaF and radiochemical purity in [18F]NaF radiopharmaceuticals. The method described for fluoride analysis uses an isocratic elution of NaF in a Hamilton anion-exchange column using a mobile phase that consists of 7.5 mM sodium carbonate and 0.018 mM potassium thiocyanate. The flow rate was 1.0 ml/min. The method was validated in accordance with several parameters, including syst...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772948</comments>
            <pubDate>Thu, 30 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772948</guid>        </item>
        <item>
            <title>Synthesis and in vivo evaluation of 201Tl(III)–DOTA complexes for applications in SPECT imaging</title>
            <link>http://www.medworm.com/index.php?rid=4772945&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004798%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Despite promising results on the labeling and in vitro stability of 201Tl(III)–DOTA, our in vivo results indicate that the integrity of 201Tl(III)–DOTA decreases to (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772945</comments>
            <pubDate>Thu, 30 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772945</guid>        </item>
        <item>
            <title>Evaluation of adenosine preconditioning with 99mTc-His10-annexin V in a porcine model of myocardium ischemia and reperfusion injury: preliminary study</title>
            <link>http://www.medworm.com/index.php?rid=4772943&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004816%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: This study addresses the feasibility of imaging of myocardial cell death in acute ischemia and RI in pigs with 99mTc-His10-annexin V; it holds prospect for the detection of myocardial cell death in clinical practice. Adenosine preconditioning could attenuate the myocardial apoptosis; its cardioprotective effect might partially be fulfilled by suppressing the ongoing apoptosis in ischemia and reperfusion. Further study is warranted. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772943</comments>
            <pubDate>Thu, 30 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772943</guid>        </item>
        <item>
            <title>[11C]diclofenac sodium: synthesis and PET assessment of transdermal penetration</title>
            <link>http://www.medworm.com/index.php?rid=4467782&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004129%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: The aim of this work was to study the feasibility of using Positron Emission Tomography (PET) imaging as a new tool to detect transdermal penetration of topical drugs in human subjects. The compound used in the study is sodium 2-[(2,6-dichlorophenyl)amino]phenyl]acetate, better known as diclofenac sodium. This molecule belongs to the family of non-steroidal anti-inflammatory drugs and is considered one of the first choices among non-steroidal anti-inflammatory drugs for the treatment of inflammatory diseases; it is widely used and commercially present in a large number of pharmaceutical forms and formulations. 11C-labeled diclofenac has been synthesized and coformulated, as an internal indicator, with a proprietary preparation based on the use of a sprayer. The radiolabeled prepa...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4467782</comments>
            <pubDate>Thu, 09 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4467782</guid>        </item>
        <item>
            <title>Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivatives</title>
            <link>http://www.medworm.com/index.php?rid=4772941&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004749%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusions: Improvements in stability were not sufficient to outweigh the low somatostatin receptor affinity for the peptides in this study. Further improvements in the peptide sequence and/or metal coordination are needed to result in a radiodiagnostic/radiotherapeutic pair for targeting the somatostatin receptor. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4772941</comments>
            <pubDate>Fri, 03 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4772941</guid>        </item>
        <item>
            <title>Biodistribution and radiation dosimetry of the α7 nicotinic acetylcholine receptor ligand [11C]CHIBA-1001 in humans</title>
            <link>http://www.medworm.com/index.php?rid=4706636&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004476%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: Effective dose estimates for [11C]CHIBA-1001 were compatible with those associated with other common nuclear medicine tests. Absorption doses among several organs were considerably different between the human and mouse studies. Human dosimetry studies for the investigation of radiation safety are desirable as one of the first clinical trials of new PET probes before their application in subsequent clinical investigations. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706636</comments>
            <pubDate>Fri, 03 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4706636</guid>        </item>
        <item>
            <title>Microwave-assisted radiosynthesis of [18F]fluorinated fatty acid analogs</title>
            <link>http://www.medworm.com/index.php?rid=4706635&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004440%2Fabstract%3Frss%3Dyes</link>
            <description>In this study, we investigate the efficiency of synthesis of terminally [18F]fluorinated fatty acid analogs using a commercial microwave reactor in comparison with conventional heating (CH).Methods: The labeling precursors were methyl esters of terminally substituted alkyl bromides and iodides. Duration and temperatures of the [18F]fluorination reaction were varied. Chemical and radiochemical purities, and radiochemical yields were investigated for conventional (CH) and microwave-assisted (MW) radiosyntheses.Results: The results demonstrate that microwave heating enhanced [18F]fluoride incorporation to &gt;95% (up to 55% improvement), while reducing reaction times to 2 min (∼10-fold reduction) or temperatures to 55–60°C (20°C reduction). Overall decay-corrected radiochemical yields of p...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706635</comments>
            <pubDate>Fri, 03 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4706635</guid>        </item>
        <item>
            <title>Microfluidic preparation of [18F]FE@SUPPY and [18F]FE@SUPPY:2 — comparison with conventional radiosyntheses</title>
            <link>http://www.medworm.com/index.php?rid=4706634&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004506%2Fabstract%3Frss%3Dyes</link>
            <description>Abstract: Introduction: Recently, first applications of microfluidic principles for radiosyntheses of positron emission tomography compounds were presented, but direct comparisons with conventional methods were still missing. Therefore, our aims were (1) the set-up of a microfluidic procedure for the preparation of the recently developed adenosine A3-receptor tracers [18F]FE@SUPPY [5-(2-[18F]fluoroethyl)2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate] and [18F]FE@SUPPY:2 [5-ethyl-2,4-diethyl-3-((2-[18F]fluoroethyl)sulfanylcarbonyl)-6-phenylpyridine-5-carboxylate] and (2) the direct comparison of reaction conditions and radiochemical yields of the no-carrier-added nucleophilic substitution with [18F]fluoride between microfluidic and conventional methods.Methods: For the...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706634</comments>
            <pubDate>Fri, 03 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4706634</guid>        </item>
        <item>
            <title>Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation</title>
            <link>http://www.medworm.com/index.php?rid=4706633&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004555%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The study demonstrated that MDP could be labeled with 177Lu with high radiochemical yields (&gt;99%). The in vitro stability of the complex was found adequate. Biodistribution studies in Sprague-Dawley rats indicated selective bone accumulation, relatively low uptake in soft tissue (except liver) and higher skeletal uptake, suggesting that it may be useful as a bone pain palliation agent for the treatment of bone metastases. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706633</comments>
            <pubDate>Fri, 03 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4706633</guid>        </item>
        <item>
            <title>Synthesis, characterization and biological evaluation of [188Re(N)(cys∼)(PNP)]+/0 mixed-ligand complexes as prototypes for the development of 188Re(N)-based target-specific radiopharmaceuticals</title>
            <link>http://www.medworm.com/index.php?rid=4706632&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS0969805110004464%2Fabstract%3Frss%3Dyes</link>
            <description>We report on an efficient procedure for the preparation of [188Re(N)(PNP)]-based complexes (where PNP is diphosphinoamine) useful in the development of target-specific radiopharmaceuticals. The radiochemical yield of the compounds was optimized considering such reaction parameters as nature of the nitrido nitrogen donor, reaction times and pH level. The chemical identity of the 188Re agents was determined by high-performance liquid chromatography comparison with the corresponding well-characterized cold Re compounds. 188Re(N) mixed compounds have been evaluated with regard to stability toward transchelation with GSH and degradation by serum enzymes. The clearance of selected radiocompounds from normal tissues and their in vivo stability were evaluated in rats by biodistribution and imaging...</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706632</comments>
            <pubDate>Fri, 03 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4706632</guid>        </item>
        <item>
            <title>Potential use of 68Ga-apo-transferrin as a PET imaging agent for detecting Staphylococcus aureus infection</title>
            <link>http://www.medworm.com/index.php?rid=4706631&amp;cid=s_38706_37_f&amp;fid=38706&amp;url=http%3A%2F%2Fwww.nucmedbio.com%2Farticle%2FPIIS096980511000452X%2Fabstract%3Frss%3Dyes</link>
            <description>Conclusion: The preliminary results suggest that 68Ga-TF is capable of detecting S. aureus infection in the rat model, within an hour after intravenous injection. (Source: Nuclear Medicine and Biology)</description>
            <author>Nuclear Medicine and Biology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4706631</comments>
            <pubDate>Fri, 03 Dec 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">4706631</guid>        </item>
    </channel>
</rss>

